Hantavirus vaccine in 2026?
hantavirus vaccine 2026. Best Yes near 5¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 5¢ · Best No: 96¢ · 1 platform
- Polymarket: Yes 5¢ / No 96¢
Hantavirus vaccine in 2026?
$135.6K
$0 24h
1
Cross-platform pricing
Resolves Jan 1, 2027
~109 days left
Culture
Opens on best-price platform
Compare & Trade
1 platform
Deposit $10, get $20 Trading Bonus for New Signups
Price History
About This Market
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Market Details
Opens on best-price platform
Compare & Trade
1 platformDeposit $10, get $20 Trading Bonus for New Signups
Sign in to join the discussion
Sign In